bims-cesirm Biomed News
on Cell Signaling mediated regulation of metabolism
Issue of 2026–04–05
seventeen papers selected by
Tigist Tamir, University of North Carolina



  1. Bioinform Adv. 2026 ;6(1): vbag084
       Motivation: Cancer metastasis is a leading cause of cancer-related deaths, while its underlying mechanisms remain incompletely understood. To colonize distant organs, cancer cells reprogram their metabolism to adapt to diverse environmental challenges. Therefore, elucidating the metabolic pathways that drive cancer metastasis will uncover novel biomarkers and therapeutic targets.
    Results: We integrated published datasets and systematically analyzed metabolites across multiple cancer cell lines. This large-scale bioinformatic analysis revealed distinct metabolites and metabolic pathways associated with organ-specific metastasis, and underscored the crucial role of tissue of origin in shaping the metabolic landscape of metastatic tumors. Notably, the transsulfuration pathway (also known as the cysteine and methionine metabolism) was strongly enriched in cancer cells with high metastatic potential. We validated this finding in pancreatic cancer, where the pathway enzyme cystathionine β-synthase (CBS) and its metabolic products were highly expressed in metastatic cancer cells. Targeting the transsulfuration pathway either by methionine deprivation or pharmacological inhibition of CBS significantly impaired the migration and invasion of metastatic pancreatic cancer cells. Taken together, our study not only provides a global view of the altered metabolic landscape in metastasis but also identifies the transsulfuration pathway as an oncogenic driver and a therapeutic target for pancreatic cancer metastasis.
    Availability and implementation: Related data used in this study can be found in the following link: https://github.com/jkyan08/metastasis-associated-metabolic-landscape.
    DOI:  https://doi.org/10.1093/bioadv/vbag084
  2. Nat Commun. 2026 Mar 28.
      The de novo design of small-molecule-binding proteins holds great promise as a potential tool to develop sensors on-demand for arbitrary small molecules. Here we combine deep learning and physics-based methods to generate a family of proteins with diverse and designable pocket geometries, which we employ to computationally design binders for six small-molecule targets. Biophysical characterization of the designed binders reveals nanomolar to low micromolar binding affinities and atomic-level design accuracy. Additionally, we use a cortisol binder to design a chemically induced dimerization (CID) system that enables the construction of a biosensor for cortisol detection. The approach described here demonstrates the potential of the NTF2 fold and deep learning-based protein design in sensor development, paving the way for future platforms to design binders and sensors for small molecules across analytical, environmental, and biomedical applications.
    DOI:  https://doi.org/10.1038/s41467-026-70953-8
  3. bioRxiv. 2026 Mar 28. pii: 2026.03.27.714830. [Epub ahead of print]
      Ubiquitin-fold modifier 1 (UFM1) is a ubiquitin-like protein (UBL) covalently attached to substrates through a dedicated enzymatic cascade (UFMylation) and removed by specific proteases. Despite a key role in endoplasmic reticulum (ER)-ribosome homeostasis, the basis by which this UBL supports cell fitness remains elusive, as the essentiality of UFMylation machinery varies widely across hundreds of cancer lines. Here, we trace a conditional dependence on the UFMylation pathway to the availability of alanine, an amino acid provided by human plasma-like medium but absent from most conventional synthetic media. We show that by facilitating the clearance of stalled ribosomes at the ER, dynamic UFMylation maintains cellular levels of glutamic-pyruvic transaminase 2 (GPT2), the primary enzyme responsible for de novo alanine synthesis in most human cancer lines. This buffering preserves the alanine pools required to sustain protein synthesis under alanine-restricted conditions. Beyond GPT2, UFM1 deficiency leads to widespread proteomic remodeling that spans diverse processes, including mitochondrial translation. Our results reveal that despite primarily targeting ER-localized ribosomes, the UFMylation system orchestrates a multi-organelle proteostasis network whose client composition and contributions to cell fitness are shaped by intrinsic factors and nutrient conditions.
    DOI:  https://doi.org/10.64898/2026.03.27.714830
  4. bioRxiv. 2026 Mar 27. pii: 2026.03.25.714193. [Epub ahead of print]
      Prostate cancer progression is characterized by dysregulated lipid metabolism, with fatty acid synthase (FASN), the rate-limiting step in de novo lipogenesis (DNL), resulting in significant accumulation of saturated lipids. Here, we investigate whether pharmacologic FASN inhibition creates a metabolic state that increases reliance on exogenous polyunsaturated fatty acids (PUFAs). Inhibition of FASN profoundly alters membrane phospholipid composition, driving compensatory incorporation of PUFAs into membrane phospholipids, thus increasing susceptibility to lipid peroxidation and oxidative damage. Combined FASN inhibition and PUFA exposure increased reactive oxygen species, induced mitochondrial hyperpolarization, and enhanced lipid peroxidation in both hormone-sensitive and castration-resistant prostate cancer models. Marked inhibition of human and murine prostate cancer organoids is achieved ex vivo . In genetically engineered, DNL-reliant Hi-Myc mice, a diet enriched in PUFAs significantly inhibited invasive carcinoma compared to a saturated fat-enriched diet. Environmental PUFAs modulate and enhance the therapeutic efficacy of FASN-targeted strategies. These findings set the stage for pharmacologic and dietary intervention in prostate cancer patients.
    DOI:  https://doi.org/10.64898/2026.03.25.714193
  5. J Physiol. 2026 Apr 03.
      Short-chain fatty acids (SCFAs), derived from peroxisomal metabolism and the gut microbiota, have been proposed as key substrates to support mitochondrial oxidative phosphorylation (OXPHOS) in extrahepatic tissues such as skeletal muscle. However, the extent to which mitochondria can oxidize SCFAs (acetate, propionate and butyrate) and the ability of exercise training and a high-fat diet (HFD) to modulate this process remains unclear. Here, we show that SCFA-supported respiration in skeletal muscle is relatively limited (18 ± 6 nmol min-1 mg-1), accounting for only ∼7% of maximal carbohydrate (pyruvate: 252 ± 41 nmol min-1 mg-1) and ∼14% of LCFA (palmitoylcarnitine)-linked respiration. Despite this low capacity, the intrinsic mitochondrial ability to oxidize palmitoylcarnitine, acetate and butyrate increased (P < 0.05: +50%) following HFD consumption, suggesting HFD rewires mitochondria to optimize lipid oxidation. By contrast, exercise training prevented these HFD-induced intrinsic mitochondrial responses. Although intrinsic changes are biologically relevant, skeletal muscle adaptation to metabolic stress also involves mitochondrial biogenesis and an expansion of the mitochondrial proteome. Proteomic analysis and citrate synthase activity revealed that, although HFD independently did not alter mitochondrial protein abundance, exercise training increased mitochondrial proteins, a response amplified in the presence of a HFD. Consequently, although exercise did not directly enhance mitochondrial SCFA-supported respiration, the combined effect of HFD and exercise predicted a greater overall capacity for SCFA oxidation because of increased mitochondrial abundance. Collectively, although SCFAs contribute minimally to mitochondrial respiration in skeletal muscle, combined HFD and exercise synergistically enhance overall OXPHOS capacity across diverse substrates, including SCFAs, primarily through increased mitochondrial protein abundance rather than intrinsic mitochondrial remodelling. KEY POINTS: Peroxisome and gut derived short-chain fatty acids (SCFA) have been proposed as an alternative metabolic fuel source to support skeletal muscle oxidative phosphorylation. The capacity and adaptability of mitochondrial SCFA oxidation remains unknown. SCFA-supported mitochondrial respiration is limited (<15%) compared to carbohydrate (pyruvate) and long-chain fatty acid linked substrates. High-fat feeding increased the intrinsic capacity of mitochondria to utilize palmitoylcarnitine, acetate and butyrate- effects prevented by 4 weeks of exercise training. Combined high-fat diet and exercise training increased skeletal muscle mitochondrial protein content in an additive manner, increasing oxidative capacity and ability to utilize both long- and SCFAs as a fuel source.
    Keywords:  exercise; high‐fat diet; mitochondria; short‐chain fatty acids; skeletal muscle
    DOI:  https://doi.org/10.1113/JP289545
  6. Mol Cell Proteomics. 2026 Mar 31. pii: S1535-9476(26)00057-5. [Epub ahead of print] 101561
      Esophageal squamous cell carcinoma (ESCC) exhibits high prevalence in China and poor prognosis despite neoadjuvant chemotherapy (NACT), with significant chemoresistance development. Tumor-associated metabolic reprogramming and NACT-induced cellular stress promote lactate accumulation, which serves as a precursor for lysine lactylation (Kla), a post-translational modification (PTM) potentially regulating cancer progression. We hypothesized that systematic characterization of the lactylome in response to NACT could reveal critical molecular mechanisms underlying treatment and identify new therapeutic vulnerabilities in ESCC. Herein, through comprehensive proteomic and lactylome profiling of tumor and adjacent normal tissues from 31 ESCC patients (with or without NACT treatment), we identified 8281 proteins and 1836 Kla sites across 62 samples. NACT induced substantial lactylome alterations with 307 differentially expressed Kla sites predominantly in non-histone proteins involved in DNA damage response and metabolic pathways. Our data revealed that while NACT-induced suppression of energy metabolism, coupled with upregulated HRD1 complex expression, may exert potential pro-apoptotic effects, the activation of ribosome biogenesis and increased nucleoprotein lactylation triggered tumor-protective mechanisms. Mechanistically, we demonstrated that DNA damage and elevated lactate levels induced PARP1 K654 lactylation, enhancing its enzymatic activity and augmenting poly(ADP-ribosyl)ation of downstream targets, potentially playing a pivotal role in chemotherapy resistance-associated pathways. This comprehensive tissue-level landscape of Kla dynamics in ESCC response to chemotherapy establishes Kla as a critical regulatory mechanism in treatment response, potentially offering novel therapeutic targets and predictive biomarkers for personalized treatment strategies.
    DOI:  https://doi.org/10.1016/j.mcpro.2026.101561
  7. Nat Metab. 2026 Apr 01.
      Acinar-to-ductal metaplasia (ADM) is a reversible cell state that facilitates pancreas repair following injury. Oncogenic KRAS mutations can progress ADM to pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC). However, the metabolic alterations in these precancerous lesions are understudied. Here, we identify global changes in central carbon metabolism genes and metabolites during ADM formation. In particular, NRF2-target genes are significantly induced in ADM. Among these, we focus on genes encoding NADPH-producing enzymes glucose-6-phosphate dehydrogenase (G6PD) and malic enzyme 1 (ME1), which participate in the regulation of oxidative stress. In mouse models of pancreatic tumourigenesis, G6PD deficiency or Me1 loss increases reactive oxygen species and lipid peroxidation, which is accompanied by accelerated formation of ADM and PanIN lesions. Notably, Me1 loss, but not G6PD deficiency, promotes faster PDAC progression. We demonstrate that oxidative stress is required for ADM, as pharmacological antioxidant treatment attenuates ADM progression in vivo and ex vivo. Conversely, depleting the antioxidant glutathione promotes precancerous lesions in primary human acinar cells and in mice. Together, our findings shed light on metabolic reprogramming in the precancerous pancreas.
    DOI:  https://doi.org/10.1038/s42255-026-01496-x
  8. Chem Soc Rev. 2026 Mar 30.
      Proteins, the major functional components of living organisms, undergo post-translational modifications (PTMs) that expand their structural and functional diversity. Recent advances in PTM profiling and functional analysis have revealed that many PTMs act as reversible modulators of protein behavior, operating with residue- and domain-level precision to reshape higher-order structures. Both biotic and abiotic catalyses are emerging means of deciphering and controlling PTMs. In this Tutorial Review, we outline how PTMs influence protein architecture across multiple structural scales and survey catalytic strategies that enable their analysis and manipulation.
    DOI:  https://doi.org/10.1039/d6cs00107f
  9. Cell Rep Med. 2026 Mar 26. pii: S2666-3791(26)00121-7. [Epub ahead of print] 102704
      Phosphoglycerate dehydrogenase (PHGDH), a rate-limiting enzyme in serine synthesis, is frequently overexpressed in cancers and promotes cancer progression. Its oncogenic role has been largely attributed to its enzymatic activity. Here, we uncover a critical noncanonical function of PHGDH in cancer; PHGDH upregulates PD-L1 expression to promote cancer immune evasion independently of its enzymatic function. Mechanistically, PHGDH binds to the serine/threonine kinase RAF1 and disrupts its interaction with 14-3-3, thereby activating RAF1 and its downstream MEK/ERK signaling to induce PD-L1 expression. Elevated PHGDH levels correlate with increased PD-L1 expression in clinical tumor samples. In preclinical mouse models, tumors with high PHGDH expression exhibit increased sensitivity to PD-1/PD-L1 blockade. Combining PHGDH inhibitors with PD-1/PD-L1 blockade significantly improves antitumor effects compared to individual treatments. These results identify PHGDH as an important PD-L1 regulator, reveal a critical noncanonical mechanism underlying PHGDH's oncogenic function, and propose a potential therapeutic strategy for cancers with PHGDH overexpression.
    Keywords:  PD-L1; PHGDH; immune evasion; immune therapy; metabolism; noncanonical function; serine synthesis
    DOI:  https://doi.org/10.1016/j.xcrm.2026.102704
  10. Front Bioinform. 2026 ;6 1722876
       Introduction: TNIK (Traf2- and Nck-interacting kinase) is a serine/threonine kinase that plays a crucial role in cytoskeletal organization, Wnt pathway activation, and cancer progression. Recent studies have implicated the role of TNIK in oncogenic signaling pathways and neuropsychiatric regulation. However, the phosphosignaling dynamics of TNIK remain largely unknown.
    Methods: To explore TNIK phosphoregulation, we systematically assembled and integrated global human phosphoproteomic datasets. We identified the predominant phosphosites based on the frequency. Relative solvent accessibility (RSA) and Phosphosite accessibility index (PAI) were calculated to determine the solvent exposure and structural flexibility of TNIK predominant phosphosites. To assess the functional significance of TNIK, we examined proteins that were differentially co-regulated with its predominant phosphosite, along with the corresponding upstream kinases, downstream substrates, and interacting proteins.
    Results: Analysis of the global human cellular phosphoproteome datasets revealed phosphosites S640, S680, S707, and S769 of TNIK to be the most frequently perturbed phosphosites across diverse experimental conditions. The results of the RSA and PAI analysis revealed that the predominant sites are located within highly solvent-exposed and structurally flexible regions. Notably, we obtained a large number of co-regulated proteins that were associated with cell growth, carcinogenesis, and apoptosis. The interactors identified were primarily enriched towards carcinogenesis. Our analysis revealed PRKAA1 and RPS6KB2 as robust upstream kinases of TNIK_S640 and TNIK_S707. We also identified many proteins involved in RNA splicing, cytoskeletal organisation, and cell migration as potential downstream substrates of TNIK.
    Discussion: Considering the challenges in targeted experimental analysis of these sites, a global co-regulation analysis approach was employed. Our results show that these phosphorylation sites in TNIK can influence carcinogenesis and related biological functions. It offers new insights into TNIK-mediated cellular functions, deepening our comprehension of its involvement in carcinogenesis and RNA splicing.
    Keywords:  TNIK; carcinogenesis; cell migration; co-regulation; phosphoproteomics
    DOI:  https://doi.org/10.3389/fbinf.2026.1722876
  11. Endocr Relat Cancer. 2026 Apr 01. pii: ERC-25-0312. [Epub ahead of print]
      Obesity, a significant risk factor for breast cancer, contributes to tumor progression by releasing proinflammatory adipokines through extracellular vesicles (EVs) secreted by adipose tissue (AT). These EVs, which are small membrane vesicles, have the potential to modulate tumor cell behavior, yet the mechanisms underlying this communication remain largely unclear. This study investigates how EVs derived from obese AT influence malignancy-related processes in MCF-7 breast cancer cells. To assess the effects of obese AT-EVs on MCF-7 cells, EVs were isolated from the adipose tissue secretome obtained from obese and lean individuals (control group). MCF-7 cells were stimulated with these EVs, and subsequent analyses were performed to assess changes in cellular functions, epithelial marker expression, and signaling pathways. Obese AT-derived EVs exhibited significantly elevated levels of TGF-β, leading to activation of the TGF-β/SMAD signaling pathway. This activation resulted in reduced E-cadherin expression and enhanced migration and invasiveness of MCF-7 cells. Additionally, these EVs were enriched in fatty acids, which fueled the tumor cells via fatty acid oxidation (FAO), further contributing to their migratory capacity. This study identifies TGF-β signaling and fatty acid oxidation as central mechanisms by which obese adipose tissue-derived EVs promote a metastatic phenotype in breast cancer cells. These findings provide insight into the molecular crosstalk between obesity and breast cancer and highlight potential targets for therapeutic intervention.
    Keywords:  Obesity. Adipose tissue. Extracellular vesicles. Breast cancer
    DOI:  https://doi.org/10.1530/ERC-25-0312
  12. FASEB J. 2026 Apr 15. 40(7): e71746
      Although endocrine therapies prevent recurrence and progression of estrogen receptor alpha (ER)-positive breast cancer, approximately one-third of patients experience recurrent disease that is rarely cured in the advanced/metastatic setting. A subpopulation of endocrine-tolerant breast cancer cells persists as residual disease that confers risk for the eventual emergence of drug resistance. An analysis of persisters that continue to proliferate despite endocrine therapy revealed the activation of pathways related to metabolism and E2F transcription factor signaling. E2F signaling is driven by cyclin-dependent kinases 4 and 6 (CDK4/6), and CDK4/6 inhibitors (CDK4/6i) are used clinically to prevent and manage endocrine resistance. CDK4/6i slowed the cycling of endocrine-tolerant persisters. Analyzing metabolic alterations induced by CDK4/6i, we found that CDK4/6i-tolerant persisters had upregulation of mitochondrial content, mitochondrial membrane potential, respiration, and reactive oxygen species (ROS). Inhibition of mitochondrial complex I further increased ROS levels and enhanced growth inhibition in both endocrine-sensitive and -resistant cell lines and patient-derived xenografts. These findings collectively offer mitochondrial respiration as a therapeutic target in CDK4/6-tolerant persister breast cancer cells to help eradicate residual disease.
    Keywords:  CDK4/6; abemaciclib; breast cancer; drug resistance; drug‐tolerant persisters; metabolism; palbociclib
    DOI:  https://doi.org/10.1096/fj.202502515RR
  13. J Mol Biol. 2026 Mar 29. pii: S0022-2836(26)00144-0. [Epub ahead of print] 169771
      Selenocysteine (Sec), the 21st proteinogenic amino acid, is a structural analog of cysteine (Cys) where its sidechain sulfur atom is substituted by selenium. Sec typically serves as the catalytic site in Sec-dependent enzymes and therefore the distinct chemical properties of selenium compared to sulfur endow these enzymes with unique characteristics that differentiate them from their Cys-dependent counterparts. In this review, we provide a systematic and comparative analysis of well-characterized Sec-dependent enzymes alongside their naturally occurring and artificially engineered Cys-dependent analogs in the context of biological function, active-site structure, catalytic property and mechanistic insight. Our analysis reveals that Sec-dependent enzymes consistently exhibit higher catalytic activities than their Cys analogs, despite sharing common catalytic architectures and catalytic mechanisms. The kinetic advantage is primarily attributable to the stronger nucleophilicity and/or the enhanced leaving-group ability of the selenolate sidechain of Sec compared to that of Cys. Furthermore, the stronger electrophilicity of selenolate confers all reviewed redox enzymes with superior oxidative resistance, while the increased acidity of selenolate enables metal-dependent formate dehydrogenases and hydrogenases to favor their reductive reactions (i.e., CO2 reduction and H2 production, respectively). Interestingly, certain natural Cys-dependent thioredoxin reductases appear to have evolved compensatory mechanisms through active-site-residue modifications to mitigate catalytic inefficiencies arising from the absence of Sec. The summarized correspondence between the chemical properties of Sec and the catalytic advantages of Sec-dependent enzymes provides a mechanistic basis for optimizing their catalytic performance via engineering of the micro-environment of Sec.
    Keywords:  Selenocysteine-dependent enzyme; catalytic activity; catalytic directionality; cysteine; oxidative resistance
    DOI:  https://doi.org/10.1016/j.jmb.2026.169771
  14. Sci Adv. 2026 Apr 03. 12(14): eaec8684
      Systemic neoadjuvant chemotherapy, often combined with immunotherapy, is the standard of care for early-stage, non-breast cancer susceptibility gene (BRCA)-mutant triple negative breast cancer (TNBC). However, up to 70% of patients retain residual disease after treatment, which is linked to recurrence and mortality within 5 years. To define mechanisms of resistance, we performed single-cell RNA sequencing on orthotopic TNBC patient-derived xenografts during a cycle of treatment with doxorubicin and cyclophosphamide (AC). Clustering identified four tumor epithelial cell populations, with basal cells enriched in residual tumors. These basal cells up-regulated C15ORF48, a paralog of the mitochondrial cytochrome c oxidase associated subunit FA4 (NDUFA4), while exhibiting reciprocal down-regulation of NDUFA4. Functionally, C15ORF48 knockdown sensitized breast cancer cells to AC, increasing reactive oxygen species (ROS) and apoptosis. Thus, the up-regulation of C15ORF48 blunts ROS accumulation and induces resistance to chemotherapy in the basal cell subpopulations. Our findings identify C15ORF48 as a potential therapeutic target for overcoming AC resistance in TNBC.
    DOI:  https://doi.org/10.1126/sciadv.aec8684
  15. J Biol Chem. 2026 Mar 31. pii: S0021-9258(26)00283-8. [Epub ahead of print] 111413
      Inorganic polyphosphate (polyP) is a linear polymer of phosphate residues linked by phosphoanhydride bonds. PolyP remains poorly understood in mammals due to its low abundance and lack of information on its metabolism. We developed a DAPI fluorescence-based assay to quantify the low levels of polyP present in mammalian cell lines and tissues, detecting an enrichment of polyP in the mitochondria compared with the nucleus and post-mitochondrial fraction. Mitochondrial polyP synthesis was found to depend on active FoF1 ATP synthase and an intact proton gradient across the inner mitochondrial membrane. Additionally, orthophosphate (Pi) is essential for mitochondrial polyP production, and ATP enhances Pi-driven polyP synthesis in isolated mitochondria. We discovered that the inositol pyrophosphate 5-InsP7, synthesized by IP6K1, regulates mitochondrial polyP levels. Mice and cells deficient in IP6K1 showed a significant reduction in mitochondrial polyP synthesis compared with wild type controls. Cells lacking IP6K1 also showed impaired mitochondrial respiration. The expression of active IP6K1, but not its catalytically inactive form, restored mitochondrial polyP synthesis in IP6K1 deficient cells, but mitochondrial respiration was rescued by expression of either active or inactive IP6K1. These data show that IP6K1 regulates mitochondrial function and polyP production both through the synthesis of 5-InsP7 and via a catalytic activity-independent mechanism. Our findings uncover a link between 5-InsP7, an energy sensor, and polyP, an energy store, in the regulation of mammalian mitochondrial homeostasis.
    Keywords:  ATP synthase; cell metabolism; inorganic polyphosphate; inositol phosphate; inositol pyrophosphates; mitochondria; mitochondrial membrane potential; mitochondrial respiration
    DOI:  https://doi.org/10.1016/j.jbc.2026.111413
  16. J Endocr Soc. 2026 Apr;10(4): bvag041
       Purpose: Hyperinsulinemia and tumor insulin receptor (IR) expression have been associated with triple negative breast cancer (TNBC) progression in preclinical models. We aimed to evaluate the expression of the IR, IGF-1 receptor (IGF-1R), and associated signaling protein expression in TNBC and their correlations with demographic and metabolic parameters in a population of women with TNBC.
    Methods: We identified cases of TNBC from our multi-institutional, cross-sectional study of self-identified Black and White women with newly diagnosed breast cancer. Survey, anthropometric, screening behavior, laboratory, and tumor pathology reports were collected, along with formalin-fixed paraffin embedded tumor samples. We performed immunohistochemistry (IHC) analysis and quantified the expression of IR, IGF-1R, phosphorylated Erk1/2 (pErk1/2), and FOXO3a. Clinical information was correlated with IHC scoring.
    Results: There were 93 TNBC cases. IHC staining and quantification found that 63% of TNBC cases stained positive for IR, 73% for IGF-1R, 67% for FOXO3a, and 43% for pErk1/2. Positive IR staining was more prevalent in Black women than White women (P = .003) and was associated with body mass index and fasting insulin on univariate analysis but was not significantly associated with age. On multivariate analysis, IR expression was associated with fasting insulin but not race. IGF-1R, FOXO3a, and pErk1/2 staining were not associated with any of these factors.
    Conclusion: Tumor IR expression was associated with higher fasting insulin, and higher fasting insulin was more prevalent among Black women. Further studies are needed to determine the importance of hyperinsulinemia and tumor IR expression in the development of TNBC.
    Keywords:  hyperinsulinemia; insulin receptor; triple negative breast cancer
    DOI:  https://doi.org/10.1210/jendso/bvag041
  17. NPJ Breast Cancer. 2026 Apr 03.
      The epidermal growth factor receptor (EGFR) is a well-established oncogenic driver in multiple epithelial cancers, yet its role in breast cancer remains elusive, with EGFR-targeted therapies showing limited clinical efficacy. Here, we demonstrate that EGFR promotes selective lymphatic dissemination in triple-negative breast cancer through a chemotactic mechanism involving the EGFR ligand TGF-α. Lymphatic endothelial cells (LECs) were identified as a tumor-associated source of TGF-α, both in a murine model and in human breast cancer, particularly upon stimulation with TGF-β1, a cytokine commonly overexpressed in breast tumors associated with lymph metastasis. We found that TGF-α-EGFR interactions elicit directional migration via STAT3 signaling, whereas the co-secreted ligand CTGF, enriched in blood endothelial cells, suppressed migration. Pharmacologic blockade of TGF-α with Fepixnebart, a first-in-class ligand-neutralizing antibody targeting TGF-α and previously not tested in oncologic indications, significantly inhibited early lymph metastasis of EGFR⁺ tumor cells. Furthermore, EGFR overexpression resulted in increased cellularity in tumor-draining lymph nodes and reduced CD8⁺ T-cell representation. Together, these findings reveal a role for the TGF-α/EGFR axis in lymph metastasis and propose a rationale for repositioning EGFR-targeted therapies toward targeting early metastatic spread and immunomodulation in breast cancer.
    DOI:  https://doi.org/10.1038/s41523-026-00941-0